In this study, cells treated with DCZ0801 showed a decrease in the content of pyruvate and lactate, with reduced levels of glycolysis enzymes (GLUT1, LDHA, MCT4, PKM2), indicating that DCZ0801 can obstruct the enhanced glycolysis in MM cells. Here, SLC2A1 is linked to Miyoshi myopathy.